STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
26.47
-1.25 (-4.51%)
Dec 3, 2024, 1:59 PM EST - Market open
STAAR Surgical Company Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for STAA stock have an average target of 43.33, with a low estimate of 31 and a high estimate of 55. The average target predicts an increase of 63.69% from the current stock price of 26.47.
Analyst Consensus: Buy
* Price targets were last updated on Nov 1, 2024.
Analyst Ratings
The average analyst rating for STAA stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 6 | 5 | 4 | 3 | 3 | 3 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 8 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $41 → $31 | Hold | Maintains | $41 → $31 | +17.11% | Nov 1, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Oct 31, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 19, 2024 |
| Stifel | Stifel | Strong Buy Maintains $50 → $44 | Strong Buy | Maintains | $50 → $44 | +66.23% | Aug 26, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $43 → $41 | Hold | Maintains | $43 → $41 | +54.89% | Aug 8, 2024 |
Financial Forecast
Revenue This Year
349.41M
from 322.42M
Increased by 8.37%
Revenue Next Year
390.29M
from 349.41M
Increased by 11.70%
EPS This Year
0.74
from 0.43
Increased by 71.58%
EPS Next Year
0.82
from 0.74
Increased by 10.93%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 361.6M | 427.4M | 510.0M | |||
| Avg | 349.4M | 390.3M | 447.9M | |||
| Low | 332.2M | 356.7M | 395.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 12.2% | 22.3% | 30.7% | |||
| Avg | 8.4% | 11.7% | 14.8% | |||
| Low | 3.0% | 2.1% | 1.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.84 | 1.08 | 1.49 | ||
| Avg | 0.74 | 0.82 | 1.13 | ||
| Low | 0.64 | 0.60 | 0.76 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 95.6% | 46.6% | 82.2% | ||
| Avg | 71.6% | 10.9% | 37.7% | ||
| Low | 47.9% | -19.0% | -6.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.